Fisky Gilbert Asa Maramis
Clinical Pathology Residency Program, Faculty of Medicine, Universitas Udayana/Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Diagnostic Value of NE-WY and MO-WY for Rapid Identification Acute Leukemia Fisky Gilbert Asa Maramis; Anak Agung Wiradewi Lestari; I Nyoman Wande; I Nyoman Gde Sudana; Sianny Herawati
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol. 32 No. 2 (2026)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v32i2.2830

Abstract

Rapid identification of acute leukemia is essential for its management. In resource-limited settings, simple, fast, and non-invasive initial screening methods are crucial for early detection. Cell population data (CPD) obtained from an automated hematology analyzer provides a new approach to identify acute leukemia quickly. Determine the ability of the width of dispersion of neutrophil fluorescence (NE-WY) and the width of dispersion of monocyte fluorescence (MO-WY), in rapidly identifying acute leukemia. The research was performed at Ngoerah Hospital Bali, focusing on patients recently diagnosed with acute leukemia. NE-WY and MO-WY values were measured using the Sysmex XN-3000 device. The study included healthy controls who had a medical check-up, and reactive controls, specifically patients with infections or inflammatory conditions. Patients who relapsed or previously received chemotherapy were excluded. A total of 228 subjects were involved in this study: 78 acute leukemia patients, 80 healthy controls, and 70 reactive controls. Distinguishing leukemia from healthy controls, the NE-WY cut-off value was 689, with sensitivity; 92.3%, specificity; 100% (p <0.001). While distinguishing from reactive controls, the cut-off value of NE-WY 857.5 was obtained, with sensitivity; 70.5%, specificity; 82.9% (p <0.001). In distinguishing leukemia from healthy controls, the cut-off value MO-WY 804 was obtained, with sensitivity; 52.6%, specificity; 96.3% (p <0.001). While distinguishing from reactive controls, the cut-off value of MO-WY 901 was obtained, with sensitivity; 46.1%, specificity; 85.7% (p = 0.299). NE-WY values indicated superior sensitivity and specificity compared to MO-WY in the early detection of acute leukemia.